CED Life Science Conference 2017 - Innovation Room
Sub-sector: Healthcare IT/Digital Health
Year Founded: 2015
Adaptive Risk Systems™, Inc. a women-owned business, is a cloud-based (SaaS) company that specializes in the development of products that mitigate risk. The company's president and co-founder, Melissa Becker, has spent 14 years as a clinical operations lead and auditor working on at-risk clinical studies and noticed a marketplace gap for an all-encompassing tool that utilizes the study monitor report information to identify, mitigate, and manage risks at clinical trial sites. Adaptive Risk Systems™' first product for the pharma industry is an intelligent risk monitoring assessment (IRMA™) tool that has been created for Clinical Research Associates and Study Managers to quickly identify and manage risks at both the investigative site and study levels. IRMA™ uses a proprietary rating algorithm that assigns built in corrective and preventative action plans based on the risk level assigned.
Melissa Becker, President
Wes Pollard, Chief Financial Officer
Krishna Bhupalam, Chief Technology Officer
KEY MILESTONES TO DATE
- Funding: To date has been internally funded by the founders for the development work and is considering investors for commercialization
- Alpha testing:
- Part 1 completed by December 30, 2016
- Part 2 to be completed by March 30, 2017
- Beta Testing completed by Aug/Sep 30, 2017
- Product launch estimate Nov/Dec 2017
Learn more about the CED Life Science Conference.